Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

  • This share is currently suspended. It was suspended at a price of 0.4999
  • There is currently no data for NTQ

Trading Statement

8 Apr 2020 07:00

RNS Number : 1290J
Enteq Upstream PLC
08 April 2020
 

8 April 2020

Enteq Upstream plc

("Enteq" or the "Company")

 

Year-end Trading and COVID 19 Update

 

Enteq, the oilfield services technology and equipment supplier, today announces an update for the financial year ended 31 March 2020.

 

The combined and inter-related impact of both the COVID-19 virus spreading and the recent drastic reduction in the oil price has had a significant impact on Enteq's current and future trading environment.

 

The health and safety of staff, their families and the broader community is our highest priority. Following advisory guidelines, our facilities in Houston have been re-organized to ensure safe working practices, together with enabling staff to work from home, where practical. All UK employees are now operating from their homes.

Enteq trading results for the year ended 31 March 2020 are anticipated to remain broadly in-line with the Board's earlier full-year expectations, with revenues in the region of $11m and Underlying Adjusted EBITDA* of around $3m. The cash balance as of 31 March 2020 was $10.2m ($11.9m as at 31 March 2019; $10.7m as at 30 September 2019) reflecting planned investments made during the year in the rental fleet, engineering projects and product development.

 

Due to the recent reduction in demand from the North American drilling market, combined with the future market uncertainties, Enteq intends to include a significant non-cash write down in the carrying value of both the intangible assets (capitalised research and development projects) and inventory holdings in the final reported accounts for this period. The total balance sheet (non-cash) reduction in relation to these write downs is expected to be approximately $6.9m.

 

Shortly after the dramatic fall in global oil price in mid-March 2020 many operators in the North American shale oil and gas sector announced measures to significantly reduce both capital expenditure and operating costs. Enteq responded by rapidly reducing its overhead cost base. The actions taken to date include:

· reducing the number of our US workforce by approximately 60%, with group wide salary reductions implemented from 1 April 2020;

· releasing all contract staff and curtailing all discretionary spend.

 

In addition, in order to further conserve cash, all Board members have agreed to take a significant proportion of their remuneration in new Enteq shares. Enteq is also in the process of applying for governmental assistance in the USA, where appropriate.

 

Enteq's secure balance sheet, combined with an adjusted cost base, will allow for continued investment in selected engineering development projects. Strong technical partnerships will also be maintained.

 

In the current circumstances it is not possible to give guidance as to the expected level of future trading in the medium term. Enteq's International markets, especially China, Russia and in Saudi Arabia (where a new partnership agreement has now been concluded), are expected to be more resilient than North America and Enteq continues to pursue opportunities in these areas.

 

The Company currently expects to report its full year results for the year ended 31 March 2020 on 17 June 2020.

 

 

For further information, please contact:

 

Enteq Upstream plc +44 (0)149 461 8739

Martin Perry, Chief Executive Officer

David Steel, Finance Director

 

Investec Bank plc (NOMAD and Broker) +44 (0)207 597 5970

Chris Treneman, Patrick Robb, David Anderson

 

 

 

* Underlying EBITDA is defined as operating profit before depreciation, amortisation, long term incentive charges and exceptional items. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDDLFBBZLXBBK
Date   Source Headline
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
8th Apr 20217:00 amRNSTrading Statement
10th Mar 202112:12 pmRNSHolding(s) in Company
2nd Mar 202112:14 pmRNSHolding(s) in Company
2nd Mar 20217:00 amRNSLaunch of a new Directional Drilling System
25th Feb 202111:44 amRNSHolding(s) in Company
22nd Feb 20211:27 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSAppointment of a Product Director
23rd Dec 20209:16 amRNSHolding(s) in Company
17th Dec 20203:01 pmRNSChange of Auditor
15th Dec 20204:09 pmRNSIssue of Equity
2nd Dec 202011:21 amRNSIssue of Equity
23rd Nov 20202:21 pmRNSHolding(s) in Company
18th Nov 20205:48 pmRNSInvestor Presentation
18th Nov 20204:25 pmRNSHolding(s) in Company
16th Nov 202012:03 pmRNSDirector/PDMR Shareholding
16th Nov 202011:54 amRNSDirector Shareholding - Correction
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 20203:01 pmRNSHolding(s) in Company
13th Nov 202011:04 amPRNHolding(s) in Company
13th Nov 20207:00 amRNSDirector/PDMR Shareholding
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20203:43 pmRNSDirector/PDMR Shareholding
12th Nov 20202:05 pmRNSSecond Price Monitoring Extn
12th Nov 20202:01 pmRNSPrice Monitoring Extension
12th Nov 202011:06 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSManagement Succession Plan
12th Nov 20207:00 amRNSInterim results for the six months
29th Sep 20202:33 pmRNSResult of AGM
29th Sep 20207:00 amRNSBoard appointment
29th Sep 20207:00 amRNSAGM Trading Statement
20th Aug 202010:06 amRNSDirector/PDMR Shareholding
18th Aug 20207:00 amRNSContract Award
14th Aug 202012:33 pmRNSHolding(s) in Company
31st Jul 202010:27 amRNSDirector/PDMR Shareholding
31st Jul 20209:00 amRNSOne2One Virtual Forum Presentation
28th Jul 20209:05 amRNSReplacement - New Technology Agreement
27th Jul 20202:00 pmRNSNew technology agreement
16th Jul 20203:42 pmRNSIssue of Equity
1st Jul 20207:00 amRNSFinal results for the year ended 31 March 2020
12th Jun 20201:30 pmRNSNotice of Results – Update
11th Jun 20205:17 pmRNSHolding(s) in Company
7th May 20203:31 pmRNSContract Award
7th May 20203:10 pmRNSContract award
5th May 202012:45 pmRNSIssue of Equity
8th Apr 20207:00 amRNSTrading Statement
24th Mar 20205:50 pmRNSBoard changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.